Post-marketing observational trials and catastrophic health expenditure.
Department of Medicine, University College London, London WC1E 6BT, UK. j.yudkin@ucl.ac.uk
John S
JS
Yudkin
D003718:Denmark; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000191:economics; D004345:Drug Industry / Q000191:economics*; D057915:Drug Substitution / Q000191:economics; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics / Q000600:supply & distribution; D007328:Insulin / Q000031:analogs & derivatives* / Q000191:economics / Q000600:supply & distribution; D040541:Marketing / Q000191:economics; D009042:Motivation; D011358:Product Surveillance, Postmarketing / Q000191:economics*
D007004:Hypoglycemic Agents; D007328:Insulin